As of 2024-12-13, the Relative Valuation of Guardant Health Inc (GH) is (119.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 34.94 USD, the upside of Guardant Health Inc based on Relative Valuation is -442.7%.
The range of the Relative Valuation is (120.27) - (118.37) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.0x - 37.4x | 31.9x |
| Forward P/E multiples | 23.6x - 28.5x | 25.8x |
| Fair Price | (120.27) - (118.37) | (119.76) |
| Upside | -444.2% - -438.8% | -442.7% |
| Date | P/E |
| 2024-12-11 | -8.60 |
| 2024-12-10 | -8.57 |
| 2024-12-09 | -8.77 |
| 2024-12-06 | -8.89 |
| 2024-12-05 | -8.95 |
| 2024-12-04 | -9.19 |
| 2024-12-03 | -8.63 |
| 2024-12-02 | -8.56 |
| 2024-11-29 | -8.59 |
| 2024-11-27 | -8.46 |
| 2024-11-26 | -8.29 |
| 2024-11-25 | -8.54 |
| 2024-11-22 | -7.87 |
| 2024-11-21 | -7.47 |
| 2024-11-20 | -7.40 |
| 2024-11-19 | -7.40 |
| 2024-11-18 | -6.98 |
| 2024-11-15 | -7.02 |
| 2024-11-14 | -7.28 |
| 2024-11-13 | -7.62 |
| 2024-11-12 | -7.17 |
| 2024-11-11 | -7.08 |
| 2024-11-08 | -6.90 |
| 2024-11-07 | -6.89 |
| 2024-11-06 | -6.10 |
| 2024-11-05 | -5.67 |
| 2024-11-04 | -5.69 |
| 2024-11-01 | -5.55 |
| 2024-10-31 | -5.28 |
| 2024-10-30 | -5.56 |
| 2024-10-29 | -5.25 |
| 2024-10-28 | -5.35 |
| 2024-10-25 | -4.95 |
| 2024-10-24 | -4.87 |
| 2024-10-23 | -4.92 |
| 2024-10-22 | -4.91 |
| 2024-10-21 | -5.02 |
| 2024-10-18 | -5.16 |
| 2024-10-17 | -4.99 |
| 2024-10-16 | -5.21 |
| 2024-10-15 | -5.20 |
| 2024-10-14 | -5.15 |
| 2024-10-11 | -5.16 |
| 2024-10-10 | -4.97 |
| 2024-10-09 | -5.04 |
| 2024-10-08 | -5.08 |
| 2024-10-07 | -5.15 |
| 2024-10-04 | -5.34 |
| 2024-10-03 | -5.26 |
| 2024-10-02 | -5.39 |